Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robert Peter

Showing results (241-250 of 505) with videos related to

Pageof 51
Sort By:
Theranostics|March 16, 2023
Human circulating small non-coding RNA signature as a non-invasive biomarker in clinical diagnosis of acute myeloid leukaemiaLin Xia, Huanping Guo, Xiao Wu, et al.
Hematological Oncology|May 24, 2022
Ruxolitinib combined with prednisone, thalidomide and danazol in patients with myelofibrosis: Results of a pilot studyShiqiang Qu, Zefeng Xu, Tiejun Qin, et al.
Oncotarget|January 22, 2015
Frequencies of SF3B1, NOTCH1, MYD88, BIRC3 and IGHV mutations and TP53 disruptions in Chinese with chronic lymphocytic leukemia: disparities with EuropeansYi Xia, Lei Fan, Li Wang, et al.
American Journal of Hematology|April 1, 2018
A prospective phase II study of low dose lenalidomide plus dexamethasone in patients with newly diagnosed polyneuropathy, organomegaly, endocrinopathy, monoclonal gammopathy, and skin changes (POEMS) syndromeJian Li, Xu-Fei Huang, Qian-Qian Cai, et al.
Journal of Hematology & Oncology|May 4, 2017
Non-driver mutations in myeloproliferative neoplasm-associated myelofibrosisBing Li, Robert Peter Gale, Zefeng Xu, et al.
Plos One|August 17, 2021
Celecoxib exhibits therapeutic potential in experimental model of hyperlipidaemiaMartins Ekor, Phyllis Elsie Owusu Agyei, Ernest Obese, et al.
Hematology (Amsterdam, Netherlands)|January 10, 2023
SARS-CoV-2-infection in the setting of autotransplants for multiple sclerosisJuan Carlos Olivares-Gazca, Robert Peter Gale, Daniela Sánchez-Bonilla, et al.
Cancer|November 7, 2025
Efficacy, safety and predictive biomarker of third-generation tyrosine kinase inhibitors with azacitidine in myeloid blast phase of chronic myeloid leukemiaMei Bao, Xiao S Zhang, Zong R Li, et al.
Plos One|June 15, 2021
Value of spectral detector computed tomography for the early assessment of technique efficacy after microwave ablation of hepatocellular carcinomaRobert Peter Reimer, Nils Große Hokamp, Julius Niehoff, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|February 24, 2016
Allogeneic Hematopoietic Cell Transplantation for Patients with Mixed Phenotype Acute LeukemiaReinhold Munker, Ruta Brazauskas, Hai Lin Wang, et al.
Pageof 51

Showing results (241-250 of 505) with videos related to

Sort By:
Pageof 51
Theranostics|March 16, 2023
Human circulating small non-coding RNA signature as a non-invasive biomarker in clinical diagnosis of acute myeloid leukaemiaLin Xia, Huanping Guo, Xiao Wu, et al.
Hematological Oncology|May 24, 2022
Ruxolitinib combined with prednisone, thalidomide and danazol in patients with myelofibrosis: Results of a pilot studyShiqiang Qu, Zefeng Xu, Tiejun Qin, et al.
Oncotarget|January 22, 2015
Frequencies of SF3B1, NOTCH1, MYD88, BIRC3 and IGHV mutations and TP53 disruptions in Chinese with chronic lymphocytic leukemia: disparities with EuropeansYi Xia, Lei Fan, Li Wang, et al.
American Journal of Hematology|April 1, 2018
A prospective phase II study of low dose lenalidomide plus dexamethasone in patients with newly diagnosed polyneuropathy, organomegaly, endocrinopathy, monoclonal gammopathy, and skin changes (POEMS) syndromeJian Li, Xu-Fei Huang, Qian-Qian Cai, et al.
Journal of Hematology & Oncology|May 4, 2017
Non-driver mutations in myeloproliferative neoplasm-associated myelofibrosisBing Li, Robert Peter Gale, Zefeng Xu, et al.
Plos One|August 17, 2021
Celecoxib exhibits therapeutic potential in experimental model of hyperlipidaemiaMartins Ekor, Phyllis Elsie Owusu Agyei, Ernest Obese, et al.
Hematology (Amsterdam, Netherlands)|January 10, 2023
SARS-CoV-2-infection in the setting of autotransplants for multiple sclerosisJuan Carlos Olivares-Gazca, Robert Peter Gale, Daniela Sánchez-Bonilla, et al.
Cancer|November 7, 2025
Efficacy, safety and predictive biomarker of third-generation tyrosine kinase inhibitors with azacitidine in myeloid blast phase of chronic myeloid leukemiaMei Bao, Xiao S Zhang, Zong R Li, et al.
Plos One|June 15, 2021
Value of spectral detector computed tomography for the early assessment of technique efficacy after microwave ablation of hepatocellular carcinomaRobert Peter Reimer, Nils Große Hokamp, Julius Niehoff, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|February 24, 2016
Allogeneic Hematopoietic Cell Transplantation for Patients with Mixed Phenotype Acute LeukemiaReinhold Munker, Ruta Brazauskas, Hai Lin Wang, et al.
Pageof 51